Status:
RECRUITING
Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
Lead Sponsor:
Helios Klinikum Pforzheim
Conditions:
Tricuspid Regurgitation
Right Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational...
Detailed Description
Significant tricuspid regurgitation is a common finding in elderly patients, with an incidence of 5.6% after the age of 70 years, according to the Framingham Heart Study. TR is an independent predicto...
Eligibility Criteria
Inclusion Criteria:
- Subjects (>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.
- Subjects eligible to receive the TriClip™
- Subjects must provide written informed consent prior to study procedure.
Exclusion Criteria:
- Subjects participating in another clinical study that may impact the follow-up or results of this study.
Key Trial Info
Start Date :
November 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05179616
Start Date
November 30 2020
End Date
November 30 2026
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helios Klinikum Pforzheim
Pforzheim, Germany, 75175